Amphastar Pharmaceuticals, Inc. (AMPH) News
Filter AMPH News Items
AMPH News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
AMPH News Highlights
- AMPH's 30 day story count now stands at 13.
- Over the past 22 days, the trend for AMPH's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
- The most mentioned tickers in articles about AMPH are TOP, DRUG and ABR.
Latest AMPH News From Around the Web
Below are the latest news stories about AMPHASTAR PHARMACEUTICALS INC that investors may wish to consider to help them evaluate AMPH as an investment opportunity.
Are Medical Stocks Lagging Arch Therapeutics (ARTH) This Year?Here is how Arch Therapeutics, Inc. (ARTH) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year. |
Wall Street Analysts Think Amphastar (AMPH) Is a Good Investment: Is It?According to the average brokerage recommendation (ABR), one should invest in Amphastar (AMPH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock? |
The Zacks Analyst Blog Highlights Amphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive TherapeuticsAmphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive Therapeutics are part of the Zacks top Analyst Blog. |
Zacks.com featured highlights include Amphastar Pharmaceuticals, Shift4 Payments, Beacon Roofing Supply, Hooker Furnishings and Hilltop HoldingsAmphastar Pharmaceuticals, Shift4 Payments, Beacon Roofing Supply, Hooker Furnishings and Hilltop Holdings are part of the Zacks Screen of the Week article. |
3 Stocks at the Forefront of Medical InnovationBoring businesses and industries typically show new faces when technology comes around; today, these biotech stocks are leading the way. |
What Awaits These 4 Drug Stocks That More Than Doubled in 2023?Here are four drug, biotech stocks, AMPH, DERM, CNTA & AQST, which have more than doubled in 2023 with room for further growth in 2024. |
5 Good Opportunities on Relative Price Strength StrategyAMPH, FOUR, BECN, HOFT and HTH are five stocks with explosive relative price strength. |
3 Reasons Why Amphastar (AMPH) Is a Great Growth StockAmphastar (AMPH) is well positioned to outperform the market, as it exhibits above-average growth in financials. |
The Cream Of The Crop: 5 Biotechs That Outrank Most StocksThe top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders. |
Will Eli Lilly's Emergency Diabetes Drug Give Amphastar Wings?AMPH stock has doubled so far this year and is in a buy zone again. It earlier bought Eli Lilly's emergency diabetes drug which can drive future growth. |